Week 9 HW: Cell-Free Sistem

General homework questions

Explain the main advantages of cell-free protein synthesis over traditional in vivo methods, specifically in terms of flexibility and control over experimental variables. Name at least two cases where cell-free expression is more beneficial than cell production.

Cell-free protein synthesis offers key advantages over in vivo systems by eliminating the complexity and limitations of the cell as a “black box.” In these systems, all components are defined and manipulable, allowing direct control over variables such as DNA concentrations, expression levels, biochemical composition, cofactors, and reaction conditions. In fact, expression can be precisely adjusted simply by varying the DNA concentration, achieving proportional regulation of each protein—something difficult to achieve in living cells. Furthermore, the system is fully customizable, allowing modification of the internal chemistry and each molecular component, which provides a level of experimental control and predictability far superior to that of traditional cell systems.

This approach is particularly advantageous in several scenarios. First, in the rapid prototyping of metabolic pathways or gene networks, as it allows the expression of multiple proteins in just a few hours directly from linear DNA, avoiding complex steps such as cloning and cell culture. Second, in applications requiring fine control of protein stoichiometry, since it is possible to simultaneously modulate the expression of multiple genes in the same system. Additionally, it is particularly useful for producing compounds or proteins that would be toxic or difficult to handle in living cells, and for on-demand biofabrication (e.g., rapid synthesis of proteins or drugs), where the simplicity and speed of the cell-free system represent a significant advantage.

Describe the main components of a cell-free expression system and explain the role of each component.

Components:

• Cell extract (transcription/translation machinery): contains ribosomes, tRNA, and associated factors that enable protein synthesis; it acts as the “functional cytoplasm” of the system and directly executes gene expression.

• Template DNA (plasmid or linear): provides the genetic information for the protein of interest; its concentration determines the level of expression and allows for quantitative modulation of protein production.

• Nucleotides (ATP, GTP, CTP, UTP): are the substrates for RNA synthesis during transcription; in addition, ATP and GTP participate as energy sources in different steps of translation.

• Amino acids: constitute the building blocks for protein synthesis; they must be present in adequate concentrations to sustain translation.

• Energy regeneration system: maintains constant ATP levels; it is essential because the system does not have its own active metabolism, and energy would be rapidly consumed without regeneration.

• Salts and ions (Mg²⁺, K⁺, etc.): stabilize the structure of ribosomes and enzymes; They regulate the efficiency and fidelity of translation.

• Cofactors and small molecules: include compounds necessary for enzymatic activity (such as NAD⁺, CoA); they allow essential biochemical reactions to occur within the system.

• Chaperones and folding factors (optional): help newly synthesized proteins acquire their correct functional structure, especially in complex proteins.

A cell-free expression system essentially consists of a cell extract containing the transcription and translation machinery (ribosomes, tRNA, initiation, elongation, and termination factors), along with the enzymes necessary for RNA and protein synthesis. This extract constitutes the system’s “functional cytoplasm” and allows genetic information to be translated into protein without the need for a living cell. Added to this is the template DNA (plasmid or linear fragment), which provides the genetic information to be expressed, and whose concentration can directly modulate protein expression levels.

Furthermore, the system includes a mixture of small molecules and cofactors: nucleotides (for transcription), amino acids (for translation), energy sources (such as ATP or regenerative systems), salts and ions that stabilize the machinery, and in some cases, chaperones or additional components that promote protein folding. A key feature is that all these components are defined and adjustable, allowing fundamental control of the system’s biochemistry, including which molecules participate and under what conditions the reaction occurs.

Why is energy provision regeneration critical in cell-free systems? Describe a method you could use to ensure continuous ATP supply in your cell-free experiment.

Energy provision and regeneration are critical in cell-free systems because transcription and translation processes are highly demanding on ATP and GTP. Unlike a living cell, where active metabolic pathways continuously regenerate these nucleotides, in a cell-free system the energy pool is rapidly depleted if a regenerative system is not implemented. This leads to premature cessation of protein synthesis and low overall system efficiency, limiting both the yield and duration of the reaction.
To ensure a continuous supply of ATP, a regeneration system based on phosphoenolpyruvate (PEP) and pyruvate kinase can be employed. In this scheme, PEP acts as a high-energy phosphate donor, enabling the sustained conversion of ADP to ATP. Alternatively, more stable and cost-effective systems can be used, such as those based on creatine phosphate/creatine kinase, or even more complex energy sources like glucose or maltodextrin coupled to regenerative enzyme pathways. These approaches allow extending the duration of the reaction and maintaining adequate energy levels for efficient protein synthesis.

Compare prokaryotic versus eukaryotic cell-free expression systems. Choose a protein to produce in each system and explain why.

Cell-free prokaryotic systems (e.g., those based on E. coli) are characterized by their high efficiency, low cost, and speed, making them ideal for large-scale production and rapid prototyping. However, they lack the machinery necessary to perform complex post-translational modifications (such as glycosylation or compartmentalization-dependent folding). In contrast, eukaryotic systems (derived from yeast, insect, or mammalian cell extracts) allow for more precise folding and the incorporation of post-translational modifications, although they are typically more expensive and less efficient. This difference aligns with the general principle that cell-free systems are highly tunable in their composition, allowing the selection of the extract source according to experimental needs.
As an example, I would choose to produce a bacterial metabolic enzyme (e.g., β-galactosidase) in a prokaryotic system, as it does not require complex post-translational modifications and benefits from the system’s high efficiency. In contrast, for a eukaryotic system, I would select an antibody or a human membrane protein, which require proper folding and possible modifications such as glycosylation to be functional. This type of choice is justified by each system’s differential ability to reproduce specific cellular conditions.

How would you design a cell-free experiment to optimize the expression of a membrane protein? Discuss the challenges and how you would address them in your setup.

To optimize the expression of a membrane protein in a cell-free system, I would design an experiment based on the system’s ability to be fully tunable in its composition. I would use an extract (preferably prokaryotic for initial simplicity) and systematically vary key conditions: DNA concentration, temperature, Mg²⁺ and K⁺ concentrations, and reaction time. In parallel, I would incorporate different membrane-mimetic environments (mild detergents, liposomes, or nanodiscs) directly into the reaction mixture, evaluating which one promotes the greatest protein solubility and activity. The design would be a parallel screening experiment, taking advantage of the system’s speed to compare multiple conditions in a short time.

The main challenge is correct folding and insertion into a lipid environment, since in the absence of a membrane, the protein tends to aggregate or lose functionality. To address this, I would include stabilizing agents (non-ionic detergents such as DDM), nanodisc systems or lipid vesicles that allow co-translational insertion, and potentially chaperones if the system allows it. Another problem is the relatively low yield, which can be mitigated by optimizing the system’s energy and DNA concentration (directly controllable).

Imagine you observe a low yield of your target protein in a cell-free system. Describe three possible reasons for this and suggest a troubleshooting strategy for each.

Low protein production in a cell-free system can be due, firstly, to an inadequate concentration or poor quality of the template DNA. Since expression depends directly on the amount of DNA present, low concentration, degradation, or impurities can limit protein synthesis. As a strategy, the DNA concentration should be optimized over a broad range and its integrity verified (e.g., by electrophoresis), taking advantage of the fact that the system allows direct modulation of this parameter.
Secondly, there may be a limitation in the provision or regeneration of energy, leading to early reaction arrest. Without an efficient ATP regeneration system, the transcription/translation machinery quickly becomes inactive. To address this, the energy system can be optimized or changed (e.g., PEP or creatine phosphate), and the reaction conditions can be adjusted to extend its duration.
Finally, a third factor can be a suboptimal biochemical environment (ions, cofactors, or protein folding), which affects translation efficiency or protein stability. Since the system is fully adjustable in its composition, concentrations of Mg²⁺ and K⁺ can be optimized, chaperones can be added, or conditions such as temperature can be modified to improve performance.

Homework question from Kate Adamala

Design an example of a useful synthetic minimal cell as follows:

1. Pick a function and describe it.
     a. What would your synthetic cell do? What is the input and what is the output?
   Chosen function: Synthetic biosensor for intestinal inflammation
   The synthetic minimal cell would be designed to detect a specific inflammatory signal (e.g., a cytokine or metabolite associated with intestinal inflammation) and respond by producing a reporter or therapeutic protein. The system’s input would be the signal molecule (e.g., TNF-α or a metabolite derived from dysbiosis), which would be recognized by a sensor module (such as a receptor or transcription-coupled regulatory system). The output would be the controlled expression of a protein, such as a fluorescent protein (for diagnostics) or an anti-inflammatory protein (for intervention).
   This design is based on the possibility of fully controlling the components of the cell-free system and programming specific gene circuits. Thus, the “cell” is not living in the strict sense, but rather a programmable minimal system where the input-output relationship is precisely defined, enabling rapid, modular, and highly specific applications.
     b. Could this function be realized by cell-free Tx/Tl alone, without encapsulation?
   Yes, this function can be performed using only a cell-free transcription/translation (Tx/Tl) system, without the need for encapsulation, especially in the case of an in vitro biosensor. The recitation highlights that these systems are fully defined and programmable, allowing gene circuits to be executed directly in solution. In this context, the biological sample acts as the input, the circuit responds, and the output (e.g., fluorescence or an enzyme signal) is generated directly in the reaction medium, without requiring a “cell” as a physical compartment. Encapsulation could become relevant depending on the objective. While it is not necessary for plate detection (where the system functions as an open biosensor), it would be useful for achieving greater stability, portability, or in situ/in vivo applications, as it would allow the system to be isolated, protected from interference, and more controlled microenvironments to be created.
     c. Could this function be realized by genetically modified natural cell?
   Yes, this function could be performed using a genetically modified natural cell, since it is possible to introduce a sensor-response gene circuit that detects a specific signal (for example, a molecule associated with inflammation) and activates the expression of a reporter or therapeutic protein. This type of design is common in synthetic biology, where inducible promoters and transcriptional regulators are used to couple an environmental input to a functional output within a living cell. Compared to the cell-free system, the use of cells introduces less experimental control and greater complexity due to endogenous regulation, metabolism, and potential unwanted interactions. While in cell-free Tx/Tl systems all components and conditions are defined and adjustable, in living cells there are limitations such as toxicity, biological variability, and lower predictability. Therefore, although feasible, the choice between the two approaches depends on the balance between control (in vitro) and integrated functionality (in vivo).
     d. Describe the desired outcome of your synthetic cell operation.

2. Design all components that would need to be part of your synthetic cell
     a. What would be the membrane made of?
   Following Kate Adamala, a synthetic cell should include a lipid bilayer membrane, typically built from phospholipids forming liposomes, to create a defined compartment that mimics cellular boundaries.

  b. What would you encapsulate inside? Enzymes, small molecules.
Inside the compartment, you would encapsulate a minimal gene expression system: DNA, RNA polymerase, ribosomes, tRNAs, enzymes, nucleotides, amino acids, and an energy regeneration system—essentially a cell-free Tx/Tl system confined within the vesicle.

  c. Which organism your Tx/Tl system will come from? Is bacterial OK, or do you need a mammalian system for some reason?
A bacterial system (e.g., E. coli) is typically used, as highlights its robustness and simplicity for building minimal cells, unless specific eukaryotic features are required.

  d. How will your synthetic cell communicate with the environment? (hint: are substrates permeable? or do you need to express the membrane channel?)
Communication is achieved by membrane permeability or engineered channels. Small molecules may diffuse passively, but for controlled exchange, membrane proteins (pores or transporters) can be incorporated to regulate input and output, enabling interaction with the environment.

Homework question from Peter Nguyen

• Write a one-sentence summary pitch sentence describing your concept.
  A smart textile embedded with freeze-dried cell-free systems that detects inflammatory biomarkers in sweat and produces a visible signal for real-time health monitoring.
• How will the idea work, in more detail?
  Inspired by Peter Nguyen, the textile would incorporate freeze-dried cell-free Tx/Tl reactions within fibers or patches. Upon contact with sweat (rehydration trigger), the system activates and detects specific metabolites or proteins associated with inflammation or stress. The embedded genetic circuit drives the expression of a colorimetric or fluorescent reporter, enabling immediate visual readout. The system remains inactive and stable until hydration, ensuring on-demand functionality.
• What societal challenge or market need will this address?
  This addresses the need for non-invasive, real-time health monitoring, particularly for chronic inflammatory conditions, athletes, or early disease detection, reducing reliance on laboratory diagnostics.
• How do you envision addressing the limitation of cell-free reactions (e.g., activation with water, stability, one-time use)?
  The system leverages freeze-drying for long-term stability and uses sweat as a natural activation mechanism. To address one-time use, the textile could incorporate replaceable sensing patches, while stability can be enhanced through protective matrices and material integration, as suggested in freeze-dried cell-free platforms.

Homework question from Ally Huang

Inspired by Ally Huang, a major challenge in space is microbial dysbiosis and altered host–microbe interactions under microgravity, which can affect astronaut health and immune function. Limited access to laboratory infrastructure makes real-time molecular diagnostics difficult. Developing portable, low-resource biosensing systems is critical for long-duration missions (e.g., Mars). Cell-free systems offer a unique solution due to their stability, programmability, and minimal requirements, making them ideal for monitoring biological changes in space environments.

• Molecular or genetic target
  Inflammation-associated cytokine mRNA (e.g., IL-6) and microbial metabolite-responsive regulatory elements.

• Relation to space biology challenge
  Altered microbiota and immune dysregulation in space can lead to increased inflammation and infection risk. Monitoring biomarkers such as IL-6 provides insight into astronaut immune status. A cell-free system can be designed to detect these molecular signals directly from biological samples (e.g., saliva), enabling rapid assessment of physiological changes without complex lab equipment.

• Hypothesis / research goal
  We hypothesize that a freeze-dried BioBits® cell-free system can be engineered to detect inflammation-associated molecular signals (e.g., IL-6 mRNA or related metabolites) in astronaut samples under microgravity conditions. Upon rehydration, the system will activate and produce a measurable fluorescent signal proportional to the target concentration. This approach leverages the stability and programmability of cell-free systems to function reliably in space. The goal is to demonstrate that biological sensing can be performed in a minimal, portable format, supporting astronaut health monitoring during long-term missions.

• Experimental plan
  Samples: simulated saliva containing target RNA or metabolites. Controls: negative (no target), positive (known concentration). Use miniPCR® to amplify target sequences if needed. Add samples to freeze-dried BioBits® reactions and incubate. Measure fluorescence using P51 viewer. Compare signal intensity across conditions to evaluate sensitivity and specificity of detection.

Homework Part B: Individual Final Project